DCM Shriram Recommends 200% Final Dividend, Approves AGM on August 18, 2026
DCM Shriram's board approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹ 4 per share, totaling ₹ 11.20 per share for FY26, pending shareholder approval. The 37th AGM is scheduled for August 18, 2026. The board also approved a ₹ 101 crore capex plan for Hindusthan Specialty Chemicals and financial assistance of up to ₹ 100 crore.
The dividend and capex plans are likely to have a moderate positive impact on investor sentiment and the company's growth prospects.
The announcement includes positive elements such as the recommendation of a final dividend, approval of financial results, and a capital expenditure plan for expansion.
DCM Shriram Limited's Board of Directors, in its meeting on 13th May 2026, approved the audited financial results (both standalone and consolidated) for the quarter and financial year ended 31st March 2026. The board recommended a final dividend of 200%, which is ₹ 4 per equity share of face value ₹ 2 each, subject to shareholder approval at the 37th Annual General Meeting (AGM). If approved, the total dividend for the financial year 2025-26 would amount to 560%, or ₹ 11.20 per equity share, including the first and second interim dividends of ₹ 3.60 per share each, declared in October 2025 and January 2026 respectively. The final dividend, if declared, will be paid within 30 days from the AGM date.
The 37th AGM is scheduled for Tuesday, 18th August 2026. Additionally, the board considered and approved, subject to shareholder approval, the cancellation of 39,00,000 forfeited equity shares of the company, with an aggregate paid-up amount of ₹ 15.60 lakhs.
Furthermore, the board reviewed and approved the capital expenditure plan of Hindusthan Specialty Chemicals Ltd (HSCL), a wholly-owned subsidiary, involving a capital investment of ₹ 101 crore to increase its Formulated Resins (FR) capacity by 36K TPA, reaching a total of 50K TPA. Financial assistance of up to ₹ 100 crore to HSCL was also approved through a mix of equity and debt. The Board meeting commenced at 11:00 A.M. and concluded at 5:15 P.M. on 13th May 2026.
What to do with a filing like this
DCM Shriram Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Limited. Read the original for the full detail.